Provost Miriam
SEC CIK 1773663 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TMDX | TransMedics Group, Inc. | VP, Gbl Regulatory Affairs | 23.3K | — | $1.09M | 14 | 2021-07-30 | 2023-12-15 |
Most active insiders at TMDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Weill David | Dir | $109.1K | $1.22M |
| 2 | Hernandez Gerardo | CFO | — | $1.25M |
| 3 | Hassanein Waleed H | Pres, CEO, Dir | $1.00M | — |
| 4 | Gunderson Thomas J. | Dir | — | $722.4K |
| 5 | Ranganath Anil P. | See remarks | — | $555.9K |
| 6 | Basile Edward M | Dir | — | $540.3K |
| 7 | Corcoran Nicholas | See remarks | — | $412.6K |
| 8 | Lovell Stephanie | Dir | — | $178.5K |
| 9 | Forsyth Matthew S. | See Remarks | — | — |
| 10 | Cecere Giovanni | Chief Commercial Off | — | — |
Provost Miriam made no open-market trades at TMDX in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-15 | 2023-12-13 | TMDX | TransMedics Group, Inc. | Provost Miriam | VP, Gbl Regulatory Affairs | M - OptEx | $44.81 | +5,644 | 27.5K | +26% | +$252.9K |
| DM | 2023-12-15 | 2023-12-13 | TMDX | TransMedics Group, Inc. | Provost Miriam | VP, Gbl Regulatory Affairs | S - Sale+OE | $75.10 | -4,122 | 23.9K | -15% | -$309.6K |
| D | 2023-12-15 | 2023-12-15 | TMDX | TransMedics Group, Inc. | Provost Miriam | VP, Gbl Regulatory Affairs | G - Gift | $0.00 | -1,785 | 23.3K | -7% | $0 |
| D | 2023-09-05 | 2023-08-31 | TMDX | TransMedics Group, Inc. | Provost Miriam | VP, Gbl Regulatory Affairs | S - Sale+OE | $66.52 | -2,708 | 23.6K | -10% | -$180.1K |
| DM | 2023-09-05 | 2023-08-31 | TMDX | TransMedics Group, Inc. | Provost Miriam | VP, Gbl Regulatory Affairs | M - OptEx | $26.98 | +5,480 | 22.6K | +32% | +$147.9K |
| D | 2023-02-22 | 2023-02-20 | TMDX | TransMedics Group, Inc. | Provost Miriam | VP, Gbl Regulatory Affairs | A - Grant | $0.00 | +5,685 | 20.8K | +38% | $0 |
| D | 2022-12-15 | 2022-12-13 | TMDX | TransMedics Group, Inc. | Provost Miriam | VP, Gbl Regulatory Affairs | M - OptEx | $38.46 | +5,918 | 19.5K | +44% | +$227.6K |
| DM | 2022-12-15 | 2022-12-13 | TMDX | TransMedics Group, Inc. | Provost Miriam | VP, Gbl Regulatory Affairs | S - Sale+OE | $62.53 | -4,315 | 15.2K | -22% | -$269.8K |
| DM | 2022-12-13 | 2022-12-09 | TMDX | TransMedics Group, Inc. | Provost Miriam | VP, Gbl Regulatory Affairs | S - Sale+OE | $59.00 | -3,613 | 13.6K | -21% | -$213.2K |
| DM | 2022-12-13 | 2022-09-02+ | TMDX | TransMedics Group, Inc. | Provost Miriam | VP, Gbl Regulatory Affairs | M - OptEx | $23.28 | +7,726 | 14.1K | +121% | +$179.9K |
| D | 2021-12-28 | 2021-12-23 | TMDX | TransMedics Group, Inc. | Provost Miriam | VP of US Regulatory, FDA Rel | M - OptEx | $3.22 | +884 | 9,438 | +10% | +$2,846 |
| D | 2021-09-17 | 2021-09-15 | TMDX | TransMedics Group, Inc. | Provost Miriam | VP of US Regulatory, FDA Rel | M - OptEx | $16.14 | +5,625 | 12.4K | +83% | +$90.8K |
| D | 2021-09-17 | 2021-09-15 | TMDX | TransMedics Group, Inc. | Provost Miriam | VP of US Regulatory, FDA Rel | S - Sale+OE | $31.34 | -3,877 | 8,554 | -31% | -$121.5K |
| D | 2021-08-03 | 2021-07-30 | TMDX | TransMedics Group, Inc. | Provost Miriam | VP of US Regulatory, FDA Rel | M - OptEx | $3.22 | +2,206 | 6,806 | +48% | +$7,103 |
Purchase Sale Sale after option exercise All abbreviations